tiprankstipranks
Advertisement
Advertisement
Biohaven announces completion of enrollment in RISE3 trial
PremiumThe FlyBiohaven announces completion of enrollment in RISE3 trial
21d ago
Biohaven falls -9.8%
Premium
The Fly
Biohaven falls -9.8%
22d ago
Biohaven enrolls first patient in Phase 3 trial of BHV-1300 for Graves’ disease
Premium
The Fly
Biohaven enrolls first patient in Phase 3 trial of BHV-1300 for Graves’ disease
22d ago
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe FlyFDA issues draft guidance to help accelerated cell, gene therapies for patients
2M ago
Biohaven initiates first-in-human dosing for BHV-8100
Premium
The Fly
Biohaven initiates first-in-human dosing for BHV-8100
2M ago
Biohaven Showcases Promising Opakalim Epilepsy Data at R&D Day
Premium
Company Announcements
Biohaven Showcases Promising Opakalim Epilepsy Data at R&D Day
2M ago
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe FlyTrump Trade: Trump to suspend tariff-rate quotas on beef imports
2M ago
Biohaven: Hold Rating Reiterated as Clinical and Competitive Uncertainties Persist; Price Target Maintained at $10
Premium
Ratings
Biohaven: Hold Rating Reiterated as Clinical and Competitive Uncertainties Persist; Price Target Maintained at $10
2M ago
Trump Trade: U.S. plans AI security order without required model tests
Premium
The Fly
Trump Trade: U.S. plans AI security order without required model tests
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100